|Articles|July 1, 2019

1 Child Dead in Cluster of E coli Cases Linked to San Diego County Fair

Four children have been diagnosed with Shiga-toxin producing E coli following a visit to the San Diego County Fair during the month of June.

A young child has died after contracting Shiga-toxin producing E coli after coming into contact with animals at a petting zoo while attending the San Diego County Fair. The young boy, who was 2 years-old, was hospitalized for his illness and later died on June 24, 2019, from a complication of the disease.

The County of San Diego Health and Human Services Agency (HHSA) issued a news release on June 28, 2019, announcing that a total of 4 children have been diagnosed with Shiga-toxin producing E coli. The 3 other children did not require hospitalization, but all visited the fair between June 8 and June 15, 2019, and had contact with the petting zoo animals or other animals onsite. The fair officials have closed public access to all animal areas, including the petting zoo, as a precaution.

HHSA is working alongside the County Department of Environmental Health to investigate the cluster of infections. As part of the epidemiological investigation the health officials inspected food facilities that the children visited at the fair but did not find any link to the E coli cluster.

The US Centers for Disease Control and Prevention notes that antibiotics should not be used to treat Shiga-toxin producing E coli, as there is no evidence that antibiotics are helpful in treating this infection. Additionally, antibiotic use may increase the risk of developing hemolytic uremic syndrome (HUS). Patients with HUS should be hospitalized in order to prevent permeant loss of kidney function.

“While most people recover from this illness without complications, 5 to 10% of people diagnosed with [Shiga-toxin producing E coli] develop the life-threatening kidney infection,” Wilma J. Wooten, MD, MPH, San Diego County public health officer said in the press release.

Symptoms of Shiga-toxin producing E coli typically develop 3-4 days following exposure to the pathogen. The symptoms can vary from person-to-person but typically include severe abdominal craps, watery or bloody diarrhea and vomiting.

HHSA reminds the public that the most important step to preventing an E coli infection is to practice good handwashing hygiene. It is important to wash your hands thoroughly following contact with animals or their environments, including farms, petting zoos, fairs, or your backyard. Young children, older individuals, and individuals with weakened immune systems should be mindful to always wash their hands prior to eating or drinking.

Contagion® will continue to provide updates on this cluster as information is made available.


Related to this article

CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.